NASDAQ: ESLA
Estrella Immunopharma Inc Stock Ownership - Who owns Estrella Immunopharma?

Insider buying vs selling

Have Estrella Immunopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jiandong XuChief Financial Officer2025-10-071,000$1.33
$1.33kBuy
Jiandong XuChief Financial Officer2025-09-221,000$1.16
$1.16kBuy
Jiandong XuChief Financial Officer2025-09-11100$1.04
$104.00Buy

1 of 1

ESLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ESLA insiders and whales buy or sell their stock.

ESLA Shareholders

What type of owners hold Estrella Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eureka Therapeutics Inc58.74%25,277,831$19.31MInsider
Armistice Capital LLC9.52%4,099,000$3.13MInstitution
Jianwei Li5.58%2,399,490$1.83MInsider
Tradeup Acquisition Sponsor LLC2.66%1,145,760$875.36kInsider
Vanguard Capital Management LLC0.89%382,469$292.21kInstitution
Cheng Liu0.69%297,437$227.24kInsider
Jiandong Xu0.66%282,188$215.59kInsider
Wells Fargo Company0.61%264,388$201.99kInstitution
Hong Zhang0.56%240,481$183.73kInsider
Geode Capital Management LLC0.37%157,485$120.32kInstitution

1 of 3

ESLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESLA12.03%68.95%Net Buying
LITS17.31%54.55%Net SellingNet Buying
NNVC3.50%96.50%
GOSS72.34%15.03%Net Buying
BCTX4.45%51.90%

Estrella Immunopharma Stock Ownership FAQ

Who owns Estrella Immunopharma?

Estrella Immunopharma (NASDAQ: ESLA) is owned by 12.03% institutional shareholders, 68.95% Estrella Immunopharma insiders, and 19.01% retail investors. Eureka Therapeutics Inc is the largest individual Estrella Immunopharma shareholder, owning 25.28M shares representing 58.74% of the company. Eureka Therapeutics Inc's Estrella Immunopharma shares are currently valued at $19.72M.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.